United States of America, ex rel. Cameron Jehl v. GGNSC Southaven LLC

District Court, N.D. Mississippi·Decided July 6, 2021·No. 3:19-cv-00091·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF MISSISSIPPI OXFORD DIVISION

UNITED STATES OF AMERICA, ex rel. CAMERON JEHL PLAINTIFF

VS. CIVIL ACTION: 3:19-CV-00091-MPM-JMV

GGNSC SOUTHAVEN, LLC et al. DEFENDANTS

ORDER This cause comes before the court on its own motion, giving the parties an opportunity to address certain concerns which it has developed regarding this case. This is a qui tam action in which plaintiff, acting pursuant to a “whistleblower” complaint filed by Relator Cameron Jehl, seeks to hold defendant GGNSC liable under the False Claims Act for seeking unlawful Medicare and Medicaid reimbursements. In alleging that the reimbursements sought by GGNSC were unlawful, plaintiff argues that they were predicated upon false information, namely that its nursing director, Lionelle Trofort, had a valid nursing license. To legally practice nursing in Mississippi and serve as Director of Nursing, Trofort had to possess either a valid Mississippi nursing license, or a valid “multi-state” license from another state that gave her the privilege to practice in Mississippi. See Miss. Code Ann. §§ 73-15-3, 73-15-22 (2013); 15 Miss. Admin. Code Pt. 16, Subpt. 1, R. 45.4.1 (2013). The Complaint1 in this case alleges that Trofort was not licensed to practice nursing at GGNSC in 2013 and 2014 pursuant to a Virginia multi-state nursing license because she was not a legal resident of Virginia and, therefore, had no “multi-state” privileges attached to her

1 This court’s references to the “Complaint” should be understood as referring to the Second Amended Complaint. Virginia license that permitted her to practice in Mississippi. The Complaint further alleges that, as a result of Trofort’s lack of a valid license to practice nursing in Mississippi while employed at Golden Living, Defendants’ certifications of compliance with applicable licensure laws in their Medicare and Medicaid reimbursement requests were false within the meaning of the FCA. The FCA imposes liability on any defendant who “knowingly presents, or causes to be

presented, a false or fraudulent claim for payment or approval,” 31 U.S.C. § 3729(a)(1)(A), or who conspires to do the same, id. § 3729(a)(1)(C). A “claim” includes a request for Medicare or Medicaid reimbursement that contains (1) a false statement (2) made knowingly or recklessly and (3) that was material. See United States ex rel. Lemon v. Nurses To Go, Inc., 924 F.3d 155, 159 (5th Cir. 2019) (citing 31 U.S.C. § 3729(b)(2)(A)); United States ex rel. Grubbs v. Kanneganti, 565 F.3d 180, 188-89 (5th Cir. 2009). This court previously denied defendant’s motion to dismiss this case, and, in so doing, it expressed its inclination to conclude that certain fact-intensive issues in it would require resolution by a jury. Specifically, this court wrote that:

In reading the arguments from both sides on this issue, this court’s impression is that they each appear to have good faith and reasonable arguments regarding the issue of knowledge. Given the inherently fact-intensive nature of this issue, this court has every expectation that, even after discovery is completed in this case, there will remain triable fact issues regarding the issue of knowledge which will require a jury to resolve. While this court would not be surprised if defendant were to eventually prevail before a jury on this issue, it is unable to agree with it that prior administrative findings regarding Trofort’s status are, as a matter of law, sufficient to bar plaintiff’s claims in this case.

[Order on dismissal at 7-8].

This court’s previously-stated inclination to let a jury decide these issues was based on one overriding assumption. Namely, this court assumed that if it chose to err on the side of allowing jurors to decide these matters, then they would have the discretion to implement a fair result in this case, both as to liability and damages. This is ordinarily a safe assumption. However, this court has not previously conducted an FCA trial, and the issue of potential damages was not raised in the parties’ briefing on the motion to dismiss. This court was therefore surprised, in reading the parties’ summary judgment briefing, to learn of the sort of damages, many of them mandatory, which might arise from the rather unique FCA damages scheme as applied to this case. This may be an instance of this court’s broad naivete, rather than

a comment on the state of the law, but it appears that calculating damages unrelated to actual harm or injury may present a potential unfairness, or even absurdity, in the law. Relator notes in his briefing that the FCA provides for a civil penalty of between $5,000 and $10,000 for each false claim, even absent a showing of actual damages. Specifically, Relator writes that: In this False Claims Act (“FCA”) case, one of the remedies is a civil penalty of not Less than $5,000 and not more than $10,000. 31 U.S.C. § 3729(a)(1).1 The FCA requires the award of civil penalties for each false claim or statement even if no damages were caused by the false claims. Id.; United States ex rel. Rudd v. Schimmels, 85 F.3d 416, 419 n.1 (9th Cir. 1996); United States ex rel. Longhi v. Lithium Power Tech., Inc., 530 F. Supp. 2d 888, 891 (S.D. Tex. 2008) (stating that “the court must assess a civil penalty” for each false claim). Relator included civil penalties in his relief requested. (See Second Am. Compl., Dkt. No. 90 at PageID: 927.)

For its part, GGNSC does not appear to dispute that the interaction between the FCA’s penalty scheme and the number of Medicaid claims which it submitted in this case would result in a staggering amount of mandatory damages, the minimum amount of which is completely outside of a jury’s (or this court’s) discretion. Indeed, GGNSC itself notes in its briefing that “the FCA provides for a civil penalty of not less than $5,000 and not more than $10,000 … because of the act of that person,” and in moving to strike the supplemental report of Relator’s expert Scott Mertie, it noted that “[b]y submitting Mertie’s new opinion, Relator seeks to increase the award potentially by $13,930,000.” [245-1 at , citing 31 U.S.C. § 3729(a)(1),] This figure is based upon Merties’ estimate of the number of claims during the period when Trofort allegedly lacked proper licensing, which was 1,393. While this court does not assume that this estimate is precisely correct, even the rough estimate represents a staggering sum (half of it mandatory) which is difficult to reconcile with any considerations of proportionality and fairness.

In seeking to combat these astronomical sums in claimed damages, GGNSC relies upon arguments that discovery violations and missed deadlines specific to this particular case should prevent Relator from obtaining access to the number of Medicaid claims filed by defendant, thereby preventing him from proving damages. This court regards this as a highly unsatisfactory approach to this issue, for a number of reasons.

Free access — add to your briefcase to read the full text and ask questions with AI

United States of America, ex rel. Cameron Jehl v. GGNSC Southaven LLC, (N.D. Miss. 2021).

United States of America, ex rel. Cameron Jehl v. GGNSC Southaven LLC (United States of America, ex rel. Cameron Jehl v. GGNSC Southaven LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related